More Company News

Redx Pharma

Poster to be presented at IBD Nordic Conference
17 Nov 2022Read More

Redx Pharma

RXC004 Phase II combination arms to open enrolment
10 Nov 2022Read More

Redx Pharma

Poster on RXC007 potential in fibrotic diseases at AFDD
07 Nov 2022Read More

Redx Pharma

Poster on Phase I RXC004 combination arm data at SITC
03 Nov 2022Read More

Redx Pharma

Poster at ASN Kidney Week
27 Oct 2022Read More

Redx Pharma

First patient dosed in Phase IIa RXC007 IPF trial
11 Oct 2022Read More

Redx Pharma

Preclinical and Phase I safety data for RXC007 at ICLAF 2022
03 Oct 2022Read More

Redx Pharma

Preclinical RXC007 data at ERS 2022
31 Aug 2022Read More

Redx Pharma

Preclinical data at ECM 2022
27 Jun 2022Read More

Redx Pharma

H122 interim results
23 Jun 2022Read More

1 2 3 4 5
Return to Redx Pharma
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).